Re: Genomic Differences between "Primary" and "Secondary" Muscle-Invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-Based Neoadjuvant Chemotherapy
Related Experiment Videos
The Journal of Urology
|March 30, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
2026 Updates to the Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer: AUA/SUO Guideline.
The Journal of urology·2026
Multiparametric MRI radiomics for preoperative prediction of tumor budding grade in rectal cancer.
Frontiers in oncology·2026
IVIM-based habitat imaging for non-invasive assessment of Ki-67 proliferation status in cervical cancer.
Frontiers in oncology·2026